REUTERS: Several major US drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc, Merck & Co and others on their efforts to develop vaccines and therapies against the novel coronavirus.
Wall Street also will be looking for any signs of weakness in the companies' big-selling products as the virus runs rampant in many US states, which may stop patients with other conditions from going to hospitals or doctors due to infection fears, as was seen earlier in the US outbreak. Pfizer, which has released early data on its vaccine candidate being developed with German biotech BioNTech SE, will kick off the week of drugmaker earnings on Tuesday morning.